Medical cannabis has been legal in Canada since 2001 and over 350,000 Canadians are medical cannabis patients. Legalization of recreational cannabis in late 2018 has driven down stigma considerably, driving more and more patients to seek therapy through medical cannabis. Canada is fast becoming a leader in medical cannabis research as forward-thinking companies and advocacy groups seek new solutions. This program aims to focus both the corporate role in the medical cannabis research as well as identify ways not-for-profits and advocacy groups are taking charge in research and development.
Keynote:Peter Aceto, CEO, CannTrust
Panel Discussion:
- Dr. Siân Bevan, Chief Science Officer, Arthritis Society
- Dr. Karen Lee, VP Research, MS Society
- Monica Kocsmaros, Director, Marketing + Communications, The Ontario Lung Association
- Blaine Pearson, Co-Founder & COO, Business of Cannabis (Moderator)
